Skip to main content
. 2019 Apr 4;2019:5702026. doi: 10.1155/2019/5702026

Figure 2.

Figure 2

High FATP4 expression displayed a significant association with short recurrence-free survival in RCC cases from this study cohort (a). The Cancer Genome Atlas data analysis by the OncoLnc tool showed that the high FATP4 expression was correlated with worse overall survival in RCC patients (b).